To understand the medical basis for patients with Elijah's Syndrome (WARS2 deficiency) and find a treatment to improve their quality of life.

To fulfill this mission, we intend to raise funds to support research into understanding the medical basis of Elijah's Syndrome. We will also be forming support groups to facilitate conversation and education among family, friends, and clinicians comprising the community of patients with similar symptoms, affected genes, or both. To date the most likely cause is a WARS2 deficiency.

Janet Holland, M.S.

Stephen Lacorazza, M.S.T.

George Law, D.Min.

Randal Skidgel, Ph.D.

Ronald Trombley

Eric Williams, Ph.D.

Eric earned his doctorate from the University of Texas Health Science Center at Houston through the Toxicology program. His doctoral dissertation focused on the cross-species characterization of the cytochrome P450 3A subfamily of drug metabolizing enzymes. In addition to the field of drug metabolism, he has expertise in the fields of pharmacology, biochemistry, genetics, and enzymology. From his postdoctoral fellowship to now, he has been employed by pharmaceutical companies to bring therapies to patients of many therapeutic areas, including neuroscience, neuromuscular disorders, cardiovascular disorders, metabolic disorders, hematology, immunology, and oncology. Eric brings his breadth of experience to our organization to improve our understanding of and develop a treatment for patients with similar symptoms to Elijah's Syndrome. His LinkedIn profile can be found here.